The frequency limit is the important number. Three a week or eight a month is a ceiling, not a suggestion, and it is there because of how the compound accumulates and how side effects build.
What is PT-141?
Also known as bremelanotide. It was developed from Melanotan 2, specifically to isolate the sexual function effect from the tanning effect.
It works through the brain, not through blood flow. PT-141 acts on melanocortin receptors in the central nervous system, affecting desire itself. That is a fundamentally different mechanism from PDE5 inhibitors like Viagra, which act on blood vessels and address mechanics.
That distinction is why it is used for low desire rather than for erectile difficulty, and why it works in women as well as men. An approved form exists for hypoactive sexual desire disorder in premenopausal women.
Reported benefits
- May help with low sexual desire in men and women
- Supports eye health
- Supports brain and cognitive health
- Supports fat loss
Side effects
First-time users may experience:
- Headache
- Joint stiffness
- Facial flushing
- Blurred vision
- Vomiting
- Temporary increase in blood pressure
- May darken skin and gums temporarily
Dawn's note: safe to use with Viagra.
The blood pressure increase is a known and expected effect of this compound rather than an unusual reaction, which matters for anyone with hypertension or cardiovascular disease. And on the Viagra point: the compounds work through different mechanisms and are used together, but both can lower or raise blood pressure in different ways, so anyone taking cardiac medication, particularly nitrates, needs a physician's input before combining anything here.
Nausea is the most common reason people stop, and it is dose-related, which is the argument for starting at 0.5 mg rather than titrating quickly.
Do your own research.
Sourcing and quality
Peptides sold outside compounding pharmacies are labelled "Not For Human Consumption and For Research Use Only." Always ask for batch-specific third-party testing.
VIGEO Health does not sell injectable peptides. Email dawn@vigeohealth.net.
Test your foundations first
Low desire has causes worth investigating before reaching for a compound: thyroid function, testosterone and oestrogen status, iron, medication effects, sleep debt, and chronic stress. Several are straightforward to test and correct.
PT-141 addresses the signal. It does not address why the signal was low.
See what the OligoScan measures
What this page does not tell you
- The research chemical form is not the approved product. An approved bremelanotide product exists for hypoactive sexual desire disorder in premenopausal women.
- Anyone with uncontrolled hypertension or cardiovascular disease should not use this without medical input, given the blood pressure effect.
- Not appropriate in pregnancy.
- Low desire warrants investigation, not just management. It can reflect thyroid disease, hormonal changes, depression, or medication effects.
- Long-term safety data does not exist.
Related
- Melanotan 2 — the parent compound
- All peptides
Questions and Answers
Q: How is PT-141 dosed? A: 0.5 mg, which is 10 ticks on an insulin syringe, given subcutaneously 45 minutes before sexual activity. The dose may be increased slowly up to 1.7 mg. No more than three doses per week or eight per month. Effects may last up to 72 hours.
Q: How does PT-141 work? A: Through melanocortin receptors in the brain rather than through blood flow. That makes it fundamentally different from PDE5 inhibitors such as Viagra, which act on blood vessels. PT-141 affects desire itself, which is why it is used for low desire rather than erectile difficulty, and why it works in women as well as men.
Q: Can PT-141 be used with Viagra? A: They act through different mechanisms and are used together. However, both affect blood pressure, and PT-141 causes a temporary increase, so anyone taking cardiac medication, particularly nitrates, or with hypertension should get a physician's input before combining them.
Q: What are the side effects of PT-141? A: First-time users may experience headache, joint stiffness, facial flushing, blurred vision, vomiting, and a temporary increase in blood pressure. Skin and gums may darken temporarily. Nausea is dose-related, which is the reason for starting at the lower dose.